Arrowhead Pharmaceuticals
ARWR
#2133
Rank
NZ$15.79 B
Marketcap
NZ$113.32
Share price
-0.68%
Change (1 day)
235.84%
Change (1 year)

Market capitalization of Arrowhead Pharmaceuticals (ARWR)

Market cap: NZ$15.79 Billion

As of January 2026 Arrowhead Pharmaceuticals has a market cap of NZ$15.79 Billion. This makes Arrowhead Pharmaceuticals the world's 2133th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Arrowhead Pharmaceuticals from 1997 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$15.79 B-5.68%
2025NZ$16.74 B300.38%
2024NZ$4.18 B-19.53%
2023NZ$5.19 B-28.5%
2022NZ$7.27 B-28.34%
2021NZ$10.14 B-7.15%
2020NZ$10.92 B14.75%
2019NZ$9.52 B455.46%
2018NZ$1.71 B342.17%
2017NZ$0.38 B133.61%
2016NZ$0.16 B-69.02%
2015NZ$0.53 B3.96%
2014NZ$0.51 B0.08%
2013NZ$0.51 B1165.37%
2012NZ$40.69 M-27.98%
2011NZ$56.51 M-32.16%
2010NZ$83.3 M81.82%
2009NZ$45.81 M-32.69%
2008NZ$68.06 M-64.37%
2007NZ$0.19 B-10.23%
2006NZ$0.21 B1.94%
2005NZ$0.20 B144.32%
2004NZ$85.45 M52493.92%
2003NZ$0.16 M168.67%
2002NZ$0.06 M-68.26%
2001NZ$0.19 M-73.64%
2000NZ$0.72 M50.62%
1999NZ$0.47 M-3.98%
1998NZ$0.49 M81.63%
1997NZ$0.27 M

End of Day market cap according to different sources

On Jan 13th, 2026 the market cap of Arrowhead Pharmaceuticals was reported to be:

NZ$15.50 Billion
by Nasdaq info icon info icon
NZ$15.90 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Alnylam Pharmaceuticals
ALNY
NZ$83.24 B 426.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
NZ$5.18 B-67.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$6.70 B-57.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
NZ$0.19 B-98.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$915.18 B 5,693.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
NZ$27.52 B 74.24%๐Ÿ‡บ๐Ÿ‡ธ USA